Salbutamol Recruiting Phase 3 Trials for Asthma, Allergic Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03468790Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.